Evidence map›Paper›PMID 32076621›Full record

ArticleBioMed research international2020

Exploration of the Pressurization Condition for Killing Human Skin Cells and Skin Tumor Cells by High Hydrostatic Pressure.

Toshihito Mitsui, Naoki Morimoto, Atsushi Mahara, Sharon Claudia Notodihardjo, Tien Minh Le, Maria Chiara Munisso, Mariko Moriyama, Hiroyuki Moriyama, Natsuko Kakudo, Tetsuji Yamaoka and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Toshihito MitsuiDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka 573-1191, Japan.ORCID https://orcid.org/0000-0003-4264-0017
Naoki MorimotoDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka 573-1191, Japan.ORCID https://orcid.org/0000-0002-0712-3172
Atsushi MaharaDepartment of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe Shin-Machi, Suita City, Osaka 564-8565, Japan.ORCID https://orcid.org/0000-0002-4075-6019
Sharon Claudia NotodihardjoDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka 573-1191, Japan.
Tien Minh LeDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka 573-1191, Japan.
Maria Chiara MunissoDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka 573-1191, Japan.
Mariko MoriyamaPharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashiosaka City, Osaka 577-8502, Japan.
Hiroyuki MoriyamaPharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashiosaka City, Osaka 577-8502, Japan.
Natsuko KakudoDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka 573-1191, Japan.
Tetsuji YamaokaDepartment of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe Shin-Machi, Suita City, Osaka 564-8565, Japan.ORCID https://orcid.org/0000-0003-0225-2407
Kenji KusumotoDepartment of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka 573-1191, Japan.
Kansai Medical University · JPKindai University · JPNational Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High hydrostatic pressure (HHP) is a physical method for inactivating cells or tissues without using chemicals such as detergents. We previously reported that HHP at 200 MPa for 10 min was able to inactivate all cells in skin and giant congenital melanocytic nevus (GCMN) without damaging the extracellular matrix. We also reported that HHP at 150 MPa for 10 min was not sufficient to inactivate them completely, while HHP at 200 MPa for 10 min was able to inactivate them completely. We intend to apply HHP to treat malignant skin tumor as the next step; however, the conditions necessary to kill each kind of cell have not been explored. In this work, we have performed a detailed experimental study on the critical pressure and pressurization time using five kinds of human skin cells and skin tumor cells, including keratinocytes (HEKas), dermal fibroblasts (HDFas), adipose tissue-derived stem cells (ASCs), epidermal melanocytes (HEMa-LPs), and malignant melanoma cells (MMs), using pressures between 150 and 200 MPa. We pressurized cells at 150, 160, 170, 180, or 190 MPa for 1 s, 2 min, and 10 min and evaluated the cellular activity using live/dead staining and proliferation assays. The proliferation assay revealed that HEKas were inactivated at a pressure higher than 150 MPa and a time period longer than 2 min, HDFas and MMs were inactivated at a pressure higher than 160 MPa and for 10 min, and ASCs and HEMa-LPs were inactivated at a pressure higher than 150 MPa and for 10 min. However, some HEMa-LPs were observed alive after HHP at 170 MPa for 10 min, so we concluded that HHP at a pressure higher than 180 MPa for 10 min was able to inactivate five kinds of cells completely.

Indexed as

Hydrostatic PressureAnnexin A5ApoptosisCell ProliferationEpidermisExtracellular MatrixFibroblastsHumansKeratinocytesMelanocytesNevus, PigmentedSkinSkin NeoplasmsAnnexin A5

Identifiers

PMID32076621
PMCPMC7013323
OpenAlexW3004290600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.